We are developing a platform of structure-based drug discovery technologies.

ConfometRx is developing a platform of structure-based drug development tools to facilitate target validation, lead identification, and lead optimization for G protein coupled receptor (GPCR) targets. This platform includes: the production of pure, functional GPCRs for high-resolution structure determination by crystallography, and the engineering of GPCRs to facilitate crystal formation; the efficient and economical expression of GPCRs for NMR-based drug discovery applications; and the generation of receptor-specific, functional antibodies for target validation, therapeutics and GPCR crystallography.

Client Website

Founder, Dr. Kobilka is Professor of Medicine, and Molecular and Cellular Physiology at Stanford University. He has been working in the G protein coupled receptor field more than 22 years.